DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20150252

Trend of Hepatitis B Surface Antigen (HBsAg) among blood donors at the blood bank of a tertiary care referral teaching hospital in Southern India

Yashovardhan A., Sreedhar Babu K.V., Jothi Bai D.S.

Abstract


Background: Blood is a scarce, but lifesaving resource; it is also the most efficient vehicle for the transmission of Hepatitis B virus (HBV). Hence there is a need for accurate screening of hepatitis B surface antigen (HBsAg) among blood donors. The present study was designed to assess the seroprevalence of HBsAg, among the voluntary and replacement blood donors in the blood bank of a tertiary care referral teaching hospital in Andhra Pradesh.

Methods: This is a prospective cross sectional analytical study conducted over a period of one and a half year. A total of 9909 donor blood samples were screened for HBsAg status using enzyme linked immunosorbent assay (ELISA). The reactive samples have been tested in duplicate using different kit. The samples reactive in all three times were considered positive. The samples which were reactive only in first test were labeled as false positive.

Results: Out of 9909 blood donors screened, 255 (2.6%) were initially reactive and 219 (2.2%) were reactive after triple testing.

Conclusions: Our study showed similar HBsAg seroprevalence as that reported by World Health Organization (WHO) statistics in intermediate zone. But there was a mild increase in HBsAg seroprevalence among donors belonging to rural areas in our region compared to the urban donors.

 


Keywords


Hepatitis B Surface Antigen, Seroprevalence, Blood donors

Full Text:

PDF

References


Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, et al. Trends in incidence and prevalence of major transfusion transmissible viral infection in the United States blood donors, 1991 to 1996. JAMA. 2000;284:229-35.

Pathak S, Chandrashekhar M. (2010) Nucleic acid testing: redefining security in blood screening Available: http://www.maxhealthcare.in/ max-medical-journal/september2010/nucleic acid testing.html. Accessed on 20-10-2012.

Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999–2009. Virol J. 2011;8:96.

Drugs and Cosmetic Act 1940, 13th Edition, 2001.

Sinha SK, Roychoudhury S, Biswas K, Biswas P, Bandopadhyay R. Prevalence of HIV, Hepatitis B, Hepatitis C and Syphilis in donor’s blood: A study from eastern part of India. Open Journal of Hematology. 2012;3:1.

TRANSCON 2011 - 36th Annual National Conference of Indian Society of Blood Transfusion and Immunohematology (ISBTI). Asian J Transfus Sci. 2012;6:59-129.

Mathai J, Sulochana PV, Satyabhama S, Nair PK, Sivakumar S. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala. Indian J Pathol Microbiol. 2002;45:319–22.

Lavanya V, Viswanathan T, Arul Sheeba Malar S, Malarvizhi A, Moorthy K. Prevalence of hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Int J Med Med Sci. 2012;4:128-37.

Makroo RN, Choudhury N, Jagannathan L, Parihar-Malhotra M, Raina V, Chaudhary RK, et al. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B& C viruses in blood donors. Indian J Med Res. 2008;127:140-7.

Fernandes H, D’souza PF, D’souza PM. Prevalence of transfusion transmitted infections in voluntary and replacement donors. Indian J Hematol Blood Transfus. 2010;26:89–91.

Jain R and Gupta G. Family/friend donors are not true voluntary donors. Asian J Transfus Sci. 2012;6:29-31.

Nazar H, Nadia N, Shazia N, Zulfiqar A, Farhat A. Prevalence of hepatitis B and hepatitis C in blood donors of Karachi. Biomedica. 2008;24:116-7.

Ado A, Alhassan S, Chonoko UG, Samaila AU. “Sero-prevalence of hepatitis B surface antigen (Hbsag) among blood donors attending Ahmadu Bello University Teaching Hospital (Abuth), Zaria, Nigeria,”. Bayero Journal of Pure and Applied Sciences. 2010;3:20–2.

Kakkar N, Kaur R, Dhanoa J. Voluntary donors-need for a second look. Indian J Pathol Microbiol. 2004;46:381-3.

Singh K, Bhat S, Shastry S. Trends in the sero-prevalence of the Hepatitis B virus infection among the blood donors of coastal Karnataka, India. J Infect Dev Ctries. 2009;3:376-9.

Kochhar AK, Singh K, Kochhar SK, Duggal G, Choudhary S, Pandey SM: A study to assess trend in seroprevalence of Hepatitis B virus infection among blood donors of Southern Haryana, India. Internet J Pathol. 2012;13.

Al-Gani FA. Prevalence of HBV, HCV and HIV-1, 2 infections among blood donors in Prince Rashed Ben Al-Hassan Hospital in North Region of Jordan. Int J Biol Med Res. 2011;2:912-6.

Patil AV, Parwar SD, Pratinidhi AK. Study of prevalence, trend and correlation between infectious disease markers of blood donors. Ind J Hemat and blood transf. 1996;14:95-102.

Rodenas JG, Bacasen LC, Que ER. The prevalence of HBsAg (+) and anti-HCV (+) among healthy blood donors at east avenue medical center, Quezon city. Phil J Gastroenterol. 2006;2:64-70.

Murugan S, Devi UP, Selvi TS. Seroprevalence of HBsAg and elevated serum alfafetoprotein among the fisherman community of Tuticorin, Tamil Nadu, South India. Journal Indian Academy of Clinical Medicine. 2010;11:180-3.

Balaji N, Nadarajah R, Sankar S, Varadhan C. Hepatitis B virus and human immunodeficiency virus infection are a public health problem even in rural communities of Vellore district, Tamil Nadu. Indian J Med Microbiol. 2009;27:80-1.

Kurien T, Thyagarajan SP, Jeyaseelam L, Peedicayil A, Rajendran P, Sivaram S, et al. Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res. 2005;121:670-5.

Sonwane BR, Birare SD, Kulakarni PV. Prevalence of seroreactivity among blood donors in rural population. Indian J Med Sci. 2003;57:405-7.

Khan NU, Siddique L, Ali I, Iqbal A, Munir I, Rashid F, et al. Prevalence of hepatitis B in blood donors of NW.F.P and FATA regions and the current scenario of HBV infection in Pakistan. African J Biotech. 2010;9:6162-6.